entertainment -WSS

entertainment

author：fashion 2025-09-06 02:13:50 - browse：37694

Jennifer Doudna Feng Zhang CRISPR — CRISPR pioneers Jennifer Doudna and Feng Zhang Illustration: STAT; Photos: AP, Getty

The revolution started in silence.

Jennifer Doudna and Emmanuelle Charpentier, now Nobelists, published their first paper announcing a new enzyme for editing DNA in Science in June 2012. It was called CRISPR-Cas9. It wasn’t until January 2013 that the first paper showing the enzyme would work in cells, from Feng Zhang, was published, also in Science. A similar paper from George Church came out at the same time.

No major media outlet covered the papers. The first story on CRISPR was published that March. But within the ivory tower of academia, it was clear something big was building, as requests for the technology poured in from other researchers and Zhang set up an assembly line in his laboratory to distribute it, with students carrying carefully packed samples to a FedEx office down the street.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： Feds fine Medicare Advantage plans for overcharging members

Wikipedia

entertainment

WSS

Apellis safety probe of eye disease drug centers on injection needle

Cardiologists urge adding sexual orientation, gender identity to health records

Study finds new variant for Parkinson’s in African populations

High breast density mammograms need follow

To bolster infectious disease surveillance, genomics powerhouses team up

High breast density mammograms need follow

knowledge

entertainment

entertainment

At least 13 dead in Texas as scorching temps continue

Prior authorization reform is both possible and imperative

How to save PrEP access — and even expand it

What causes osteoarthritis? Researchers study link to brain protein

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Feds fine Medicare Advantage plans for overcharging members

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Maisha Meds is a PBM, but don't call it that

Jerome Adams on the need for new antivirals for Covid

The inclusion problem at the heart of rehabilitation research

leisure time

Immunocompromised patients offer clues on chronic Covid

TikTok, Instagram influencers need more rules for drug ads

Mass General, Mayo Clinic look to monetize custom

Why more medical students aren't specializing in primary care

Why more medical students aren't specializing in primary care

CVS is on a mission to consolidate health care. Will it work?

knowledge

Wikipedia

entertainment

focus